• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cyclosporine for refractory Kawasaki disease with psoriasiform eruption.

作者信息

Leyendecker Mara, Wanner Brian, Hammon Brad, Erdem Guliz, Fung Bonita, Fernandez Faith Esteban

机构信息

Ohio University Heritage College of Osteopathic Medicine, Athens, Ohio.

Division of Dermatology, OhioHealth Riverside Methodist Hospital, Columbus, Ohio.

出版信息

JAAD Case Rep. 2021 Feb 17;10:89-91. doi: 10.1016/j.jdcr.2021.02.004. eCollection 2021 Apr.

DOI:10.1016/j.jdcr.2021.02.004
PMID:33786356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7994436/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d617/7994436/5e7c21cc1a52/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d617/7994436/86a255ca57be/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d617/7994436/652ec86dbc12/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d617/7994436/5e7c21cc1a52/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d617/7994436/86a255ca57be/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d617/7994436/652ec86dbc12/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d617/7994436/5e7c21cc1a52/gr3.jpg

相似文献

1
Cyclosporine for refractory Kawasaki disease with psoriasiform eruption.环孢素用于治疗伴有银屑病样皮疹的难治性川崎病。
JAAD Case Rep. 2021 Feb 17;10:89-91. doi: 10.1016/j.jdcr.2021.02.004. eCollection 2021 Apr.
2
Kawasaki disease: a comprehensive review of treatment options.川崎病：治疗选择的全面综述
J Clin Pharm Ther. 2015 Dec;40(6):620-5. doi: 10.1111/jcpt.12334. Epub 2015 Nov 7.
3
Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.静脉注射免疫球蛋白γ（IVIG）与 IVIG 联合英夫利昔单抗治疗川崎病患儿的比较
Med Sci Monit. 2018 Oct 11;24:7264-7270. doi: 10.12659/MSM.908678.
4
Adjunct cyclosporine therapy for refractory Kawasaki disease in a very young infant.辅助环孢素治疗极幼龄婴儿难治性川崎病。
Pediatr Int. 2016 Apr;58(4):295-8. doi: 10.1111/ped.12778. Epub 2015 Dec 16.
5
Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.难治性川崎病患者治疗选择的间接比较荟萃分析。
BMC Pediatr. 2019 May 17;19(1):158. doi: 10.1186/s12887-019-1504-9.
6
Psoriasiform eruption with arthritis post infliximab use in Kawasaki disease.川崎病使用英夫利昔单抗后出现的银屑病样皮疹伴关节炎。
Pediatr Int. 2022 Jan;64(1):e15232. doi: 10.1111/ped.15232.
7
Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome.川崎病静脉注射免疫球蛋白治疗的经济学评价
J Pediatr. 1993 Apr;122(4):538-42. doi: 10.1016/s0022-3476(05)83532-2.
8
Management of acute and refractory Kawasaki disease.川崎病急性期和难治性川崎病的治疗。
Expert Rev Anti Infect Ther. 2012 Oct;10(10):1203-15. doi: 10.1586/eri.12.101.
9
Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?英夫利昔单抗联合静脉注射免疫球蛋白（IVIG）与单独 IVIG 作为有冠状动脉损伤的川崎病患儿初始治疗的比较：双治疗更有效吗？
Pediatr Infect Dis J. 2018 Oct;37(10):976-980. doi: 10.1097/INF.0000000000001951.
10
Aspirin Dose in Kawasaki Disease: The Ongoing Battle.川崎病阿司匹林剂量：持续的战斗。
Arthritis Care Res (Hoboken). 2018 Oct;70(10):1536-1540. doi: 10.1002/acr.23504. Epub 2018 Sep 7.

本文引用的文献

1
Refractory Kawasaki disease: diagnostic and management challenges.难治性川崎病：诊断与管理挑战
Pediatric Health Med Ther. 2019 Oct 30;10:131-139. doi: 10.2147/PHMT.S165935. eCollection 2019.
2
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.川崎病患儿对静脉注射免疫球蛋白无反应风险较高者，采用免疫球蛋白加环孢素进行初级治疗预防冠状动脉异常的疗效（KAICA）：一项随机对照、开放标签、盲终点、3 期临床试验。
Lancet. 2019 Mar 16;393(10176):1128-1137. doi: 10.1016/S0140-6736(18)32003-8. Epub 2019 Mar 7.
3
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理：美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.
4
Kawasaki disease: etiopathogenesis and novel treatment strategies.川崎病：病因发病机制与新型治疗策略
Expert Rev Clin Immunol. 2017 Mar;13(3):247-258. doi: 10.1080/1744666X.2017.1232165. Epub 2016 Sep 13.
5
Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype.川崎病（KD）期间的银屑病样皮疹：一种独特的表型。
J Am Acad Dermatol. 2016 Jul;75(1):69-76.e2. doi: 10.1016/j.jaad.2016.02.1146. Epub 2016 Mar 4.
6
Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease.难治性川崎病患儿的药物治疗选择概述
J Pediatr Pharmacol Ther. 2015 May-Jun;20(3):163-77. doi: 10.5863/1551-6776-20.3.163.
7
Association of psoriasis-like eruption and Kawasaki disease.银屑病样皮疹与川崎病的关联。
J Dermatol. 2006 Aug;33(8):571-3. doi: 10.1111/j.1346-8138.2006.00134.x.
8
Psoriatic eruption in Kawasaki disease.川崎病中的银屑病样皮疹。
J Pediatr. 2000 Oct;137(4):578-80. doi: 10.1067/mpd.2000.107840.